Health Canada Approves Novo’s Ozempic To Reduce Risk Of Kidney Function Decline, Cardiovascular Death
The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1...
Novos
The approval from Health Canada for the indications is based on the results of a trial in which Semaglutide 1...
